DIN 02500663 — JAMP GEFITINIB 250 MG
JAMP GEFITINIB is a tablet of Gefitinib marketed by JAMP PHARMA CORPORATION. The full Gefitinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02500663
- Brand name
- JAMP GEFITINIB
- Active ingredient
- Gefitinib
- Strength
- 250 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Gefitinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02468050 | APO-GEFITINIB | 250 MG | TABLET | APOTEX INC | MARKETED |
| 02248676 | IRESSA | 250 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED |
| 02491796 | NAT-GEFITINIB | 250 MG | TABLET | NATCO PHARMA (CANADA) INC | DORMANT |